Passion and Purpose.

At Flamingo, cancer patients are at the center of everything we do.  Our mission is to bring innovation to the field of oncology by creating new, targeted medicines based on novel antisense chemistries that improve the lives of patients.

We are looking to expand our flock with people who share our passion and purpose.

Send us a Message.
Flamingo Therapeutics
General Email:

For information and media requests:
Amy Conrad

Flamingo Therapeutics is a biotech R&D company with an advanced antisense RNA-targeting oncology portfolio, with three clinical programs targeting undruggable transcription factors and splice variants. The company also has a proprietary discovery engine, FLAME™ (Flamingo LncRNA Antisense Mining Engine), that addresses long non-coding RNAs (lncRNAs), a large and untapped class of disease-causing targets within the “dark matter” of the human genome. The Company was founded in 2020 based on pioneering work in the field of lncRNAs in oncology with our academic partners at VIB, KU Leuven, Ghent University and The University of Michigan. Flamingo has a strategic partnership with Ionis Pharmaceuticals and is supported by well-known biotechnology investors. The company’s research facilities are based in Leuven, Belgium and is funded by top tier European investors.

Why do we need you?
Flamingo Therapeutics is looking for a motivated and proactive discovery biologist to head target discovery efforts and initiate evaluation of long non-coding RNA targets, reporting to our Chief Scientific Officer (CSO). The successful candidate has an excellent (preferably international) academic track record with high-impact publications in the field of cancer biology and/or immunotherapy. You have experience with cellular and in vivo oncology models and are familiar with standard assays and readouts for proliferation and cell death. You routinely use standard bioinformatics tools and in silico resources, including TCGA and CCLE, and can implement more advanced tools for e.g. RNAseq and/or single-cell gene expression analyses. You will collaborate with multiple academic groups and will contribute to writing grants to obtain non-dilutive funding to further expand the team and the discovery efforts. This position requires both desk-and lab work to set up new assays and carry out in vitro testing of compounds with support from a technician. You can clearly communicate your results orally and will prepare data reports for the CSO and collaborators through the use of an electronic lab notebook system and slide presentations. You will attend regular (online) meetings with colleagues and collaborators in the USA or Asia, outside of (European) office hours.

The successful candidate should thrive in small-team environments where self-sufficiency, initiative and flexibility are key and lines of communications are short. You will join a small international team and you will contribute to a collaborative, interactive, diligent and science-driven culture in order to meet benchmarks and milestones set by the company and its investors. While this role is mainly in target discovery and validation, you will be exposed to all stages of the drug development process, from discovery to the clinic.

Which person fits our team?

  • Applicants must have a PhD a degree in Biomedical, Biological Sciences in cancer biology, several years of postdoc/industry experience and have experience in cancer target research work.
  • Fluency in English (verbally and in writing) is mandatory.
  • Solution-driven mindset.
  • Team player, applying your expertise to drive projects within a small team
  • Strong interpersonal and communication skills that you can put to use within the team as well as with collaborators
  • Meticulous, independent and self-motivated.
  • Keen to take on responsibilities.
  • The applicant must have the right to work in Belgium

Interested to join the flock? Submit your resume and motivation letter through: